Docket Room
HB 533·AL·house

Public health, authorized forms of single-dose epinephrine used by public schools and authorized entities expanded

EnactedFiled Mar 3, 2026
Sponsor: Margie Wilcox (R)
Latest Action

Enacted

Apr 17, 2026

Summary

The law allows schools, authorized entities, and trained staff to keep any FDA‑approved single‑dose pre‑measured epinephrine device, not just traditional autoinjectors, for treating life‑threatening allergic reactions. Students may also carry and self‑administer these devices when proper parental and medical authorizations are on file. The measure also gives participating schools and personnel immunity from civil liability related to the use of the medication.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Share

Track this bill

Get real-time alerts when HB 533 changes status, plus AI-powered summaries and stage predictions.

Sign up free
Docket Room · Nonpartisan legislative tracking
Docket Room IntelligencePro

Ask about your legislation

I can analyze your tracked bills, upcoming hearings, and recent changes.

AI-generated · Nonpartisan · Not legal advice